BiolineRx Ltd. (BLRX)

Oncology Corporate Profile

Stock Performance

1.0100
0.0100

3 Month Stock History Chart

HQ Location

19 Hartum Street, P.O. Box 45158
Jerusalem, Israel 91450

Company Description

BioLineRx is a publicly-traded, clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates. The Company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.

Website: http://www.BiolineRx.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BL-8040CXCR4 peptide inhibitorVarious cancer typesII
BL-8040 (+ atezolizumab)CXCR4 peptide inhibitorAcute Myelogenous Leukemia (AML)IGenentech/Roche
AGI-134immunotherapyVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.BiolineRx.com

Recent News Headlines

8/21/2017 06:18 am

8/21/2017 06:18 am

8/21/2017 06:18 am

8/21/2017 06:18 am

8/21/2017 12:18 am

8/21/2017 12:18 am

8/21/2017 12:18 am

8/21/2017 12:18 am

8/8/2017 06:17 am

8/8/2017 06:17 am

8/8/2017 06:17 am

8/8/2017 06:17 am

8/8/2017 12:17 am

8/8/2017 12:17 am

8/8/2017 12:17 am

8/8/2017 12:17 am

8/8/2017 12:17 am

8/1/2017 06:17 pm

8/1/2017 06:17 pm

8/1/2017 06:17 pm

8/1/2017 12:17 pm

8/1/2017 12:17 pm

8/1/2017 06:22 am

8/1/2017 12:18 am

7/21/2017 06:17 am